NMPA Approval

Tirofiban Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20183440

Company石药集团恩必普药业有限公司

Registration Date

July 21, 2023

Drug Information

Generic Name

盐酸替罗非班氯化钠注射液

Dosage Form

注射剂

Strength

100ml:盐酸替罗非班(以C22H36N2O5S计)5mg与氯化钠0.9g

Drug Type

化学药品

Registration Date

July 21, 2023

Company Information

Applicant Company

Company Name石药集团恩必普药业有限公司

Company Address

石家庄经济技术开发区扬子路88号

Manufacturing Company

Company Name石药集团恩必普药业有限公司

Company Address

石家庄经济技术开发区扬子路88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班氯化钠注射液 - NMPA 批准文号 | MedPath